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During eye development,apoptosisis vitalto the maturation of highly specialized structures suchasthe lensand retina. Several
forms of apoptosis have been described, including anoikis, a form of apoptosis triggered by inadequate or inappropriate
cell–matrix contacts.Theanoikis regulators, Bit1 (Bcl-2 inhibitoroftranscription-1) andprotein kinase-D(PKD), are expressed in
developing lens when the organelles are present in lens ﬁbers, but are downregulated as active denucleation is initiated. We
have previously shown that in rats with a spontaneous mutation in the Cryba1 gene, coding for bA3/A1-crystallin, normal
denucleation of lens ﬁbers is inhibited. In rats with this mutation (Nuc1), both Bit1 and PKD remain abnormally high in lens ﬁber
cells. To determine whether bA3/A1-crystallin has a role in anoikis, we induced anoikis in vitro and conducted mechanistic
studies on astrocytes, cells known to express bA3/A1-crystallin. The expression pattern of Bit1 in retina correlates temporally
withthedevelopmentofastrocytes.OurdataalsoindicatethatlossofbA3/A1-crystallininastrocytesresultsinafailureofBit1to
be trafﬁcked to the Golgi, thereby suppressing anoikis. This loss of bA3/A1-crystallin also induces insulin-like growth factor-II, which
increases cell survival and growth by modulating the phosphatidylinositol-3-kinase (PI3K)/AKT/mTOR and extracellular signal-
regulatedkinasepathways.WeproposethatbA3/A1-crystallinisanovelregulatorofbothlifeanddeathdecisionsinocularastrocytes.
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The eye has provided crucial insights into the processes and
mechanisms of development, from tissue induction to the
apoptosis-mediated remodeling required for maturation of
highly specialized structures such as the lens and retina.
1–4
Apoptosis has a crucial role during development, tissue
homeostasis and disease. Several forms of apoptosis have
been described, including anoikis, which is initiated by loss of
cell anchorage.
5,6 Two proteins, Bit1 (Bcl-2 inhibitor of
transcription-1) and its upstream regulator, protein kinase-D,
or protein kinase-D (PKD), have been shown to control
anoikis.
7 Bit1 was reported as a mitochondrial protein that
promotescaspase-independentapoptosiswhenreleasedinto
the cytoplasm.
8 However, a recent study has shown that Bit1
localizes to the early secretory pathway in the endoplasmic
reticulum (ER) microdomains and is enriched in the Golgi
complex.
9 The apoptotic function of Bit1 is inhibited by
integrin-mediated cell attachment.
7
It has been suggested that several pathways could
contribute to protection of cells from anoikis.
10,11 Bit1
negatively regulates the extracellular signal-regulated kinase
(ERK) mitogen-activated protein kinase (MAPK) survival
pathway.
12 Phosphatidylinositol-3-kinase (PI3K)/AKT/mTOR
(mammalian target of rapamycin) has been postulated to
mediate anoikis-suppressing effects in cells.
12 Interestingly, a
macrophage-stimulating protein has been shown to protect
epithelialcellsfromcelldeaththroughboththeERKandPI3K/
AKT pathways.
13 Several growth factors, for example insulin-
like growth factor-II (IGF-II), are also known to activate cell
survival pathways that promote proliferation and inhibit
apoptosis.
14 The precursor form of IGF-II (proIGF-II), but
not mature IGF-II (mIGF-II), is a potent activator of the PI3K/
Akt and ERK signaling cascades.
15
In the eye, programmed removal of nuclei and other
organelles from lens ﬁber cells is essential to remove light-
scattering centers and provide an optically clear path to the
retina. Denucleation in normally differentiating lens ﬁber cells
involves many of the cellular and molecular events of
apoptosis.
16–18 However, although lens ﬁber cells lose their
organelles, as in apoptosis, they do not die; rather, they
remainviablethroughoutlife.Themechanismsinvolvedinthis
apoptosis-like process in the lens remain largely unknown.
We have shown that a spontaneous mutation (Nuc1) in the
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www.nature.com/cddisCryba1 gene, coding for bA3/A1-crystallin, an abundant
structural protein of lens ﬁbers,
19,20 inhibits normal denuclea-
tion of lens ﬁbers.
21 Like other crystallins, bA3/A1-crystallin is
also expressed outside of the lens and probably has a role
beyondthatofa structuralprotein. Wehaveshownearlier that
in the neural retina, bA3/A1-crystallin is expressed by
astrocytes.
22 We have also provided novel evidence, based
on our studies using Nuc1 rat, that this protein has a pivotal
role in the migration, proliferation and patterning of retinal
astrocytes.
22,23
Astrocytes are one of the two glial cell types found in the
retina. Several studies have shown that all types of retinal
neurons and the Muller glial cells descend from a common
progenitor.
24,25 However, astrocytes originate outside of the
retina, arising from the neuroepithelial cells that form the optic
stalk, the primordium of the optic nerve.
26 They migrate from
the optic nerve into the inner retina, increasing in number until
6 weeks after birth.
27,28 It has been shown that during
postnatal development of the rat optic nerve 50% of
oligodendrocytes normally die, but no astrocyte death was
observed.
27 Moreover, in the early postnatal rat cerebellum, a
majorityofastrocytesareeliminatedasamechanismtoadjust
their numbers to the needs of the tissue.
29 It is possible that
duringdevelopmentastrocytecellnumbersarecontrolledbya
differentapoptotic process than all other retinal cell types. Our
previous studies suggest that astrocytes have a pivotal role in
the remodeling of the retina; therefore, maintaining a proper
astrocyte cell number is critical.
22
We report here that both Bit1 and PKD are differentially
expressed in lens during the denucleation process. However,
in Nuc1 homozygous lenses, where the mutation inhibits
normaldenucleationoflensﬁbers,expressionofbothBit1and
PKD remain abnormally high. These data prompted us to
investigate a possible role for bA3/A1-crystallin in anoikis-
mediated cell death. As we have reported earlier that
astrocytes in the neural retina express bA3/A1-crystallin and
regulate the remodeling of the retina, we investigated the
possibility that astrocyte cell numbers might be regulated by
anoikis.
We propose that bA3/A1-crystallin is required by astrocytes
fortrafﬁckingofBit1totheGolgi,whichisessentialforanoikis-
mediated cell death. Our data also indicate that loss of
bA3/A1-crystallininducesIGF-IIandincreasescell survivalby
regulating the PI3K/AKT/mTOR and ERK pathways, thereby
protecting astrocytes from anoikis-mediated cell death.
Results
Expression pattern of Bit1 during lens denucleation. To
test our hypothesis that anoikis is involved in lens
denucleation, we compared immunoﬂuorescent staining for
Bit1 in lenses from wild-type (wt) and Nuc1 homozygous rats
ranging from E (embryonic day) 14.5 to P (postnatal day) 10
(Figure 1). At E14.5, when the posterior epithelial cells of the
lens vesicle are elongating to form primary ﬁbers, there is
weak staining for Bit1, primarily in the ﬁbers, in both
genotypes. At E17.5, when the primary ﬁber cells have
ﬁlled the lens vesicle, both wt and Nuc1 lenses were strongly
positive for Bit1 in ﬁbers and epithelial cells. At E19.5 in the
wt lens, secondary ﬁbers in the bow region, as well as central
primary ﬁbers, were positive for Bit1, as was the lens
epithelium; in Nuc1 lenses, Bit1 was seen throughout the
disorganized lens. By P3, the wt lenses lose Bit1 expression
in the central ﬁber cells, with weak expression remaining in
the younger, peripheral ﬁber cells. At P10, staining at the
periphery was further decreased in the wt lens, with only
epithelial cells and ﬁbers in the bow region being positive. By
contrast, staining in Nuc1 lenses at P3 and P10 remained
strong throughout the lens.
PKD expression pattern during lens denucleation. To
determine whether PKD, the upstream regulator of Bit1, was
expressed in lens, and whether expression correlated with
denucleation, frozen sections of lenses from the same stages
as above were examined by immunoﬂuorescence.
Interestingly, we found that PKD staining showed a similar
pattern to Bit1 in the wt lens except that epithelial cells were
negative (Figure 2A). Speciﬁcally, PKD was expressed in
primary ﬁber cells by E14.5. By E19.5, PKD was expressed
throughout the lens ﬁber mass, similarly in wt and Nuc1
lenses. PKD expression in the wt lens started to decrease by
P3 and was clearly downregulated by P10. However, as with
Bit1, PKD expression was sustained in Nuc1 lens both at P3
and P10. Western blot analysis conﬁrmed that PKD protein
decreased in wt lens at P3 and P10, whereas no such
decrease occurred in Nuc1 (Figure 2B).
Bit1 expression in optic nerve and retinal
astrocytes. We have shown previously that bA3/A1-
crystallin is expressed in the wt neural retina and the optic
nerve. Expression of the anoikis regulators, Bit1 and PKD,
has not been shown previously in the retina, or in astrocytes.
In the rat optic nerve, Bit1 expression was evident by E19
(Figure 3A, a); by P3, Bit1 and glial ﬁbrillary acidic protein
(GFAP) were strongly co-expressed, indicating that mature
astrocytes express Bit1 (Figure 3A, d–f). Interestingly, at
P10, GFAP
þ optic nerve astrocytes no longer express Bit1
(Figure 3A, g–j). Bit1 expression in postnatal retina showed a
similar pattern. Retinal ﬂat mounts from wt rats showed that
GFAP
þ astrocytes (green) also expressed Bit1 (red) at P3
(Figure 3B, a–c). However, by P10 the expression of Bit1
(red) shifted from astrocytes (green) to probably Muller cells
(Figure 3B, d–f). Astrocytes migrate from the optic nerve into
the inner retina and increase in number until 6 weeks after
birth. Our data show that at 2 months of age, Bit1 was
expressed in the wt optic nerve, co-expressing with GFAP
þ
astrocytes (Figures 4a–c). In the neural retina, however, Bit1
does not co-express strongly with GFAP; rather, it appears to
be expressed predominantly by Muller glial cells (Figures 4d–f).
We have reported earlier that the Nuc1 mutation affects
programmed cell death, and we ﬁnd much stronger co-
expression of Bit1 with GFAP in the Nuc1 retina (Figures 4j–l,
arrows in panel l show co-expression). The pattern of Bit1
expression in Nuc1 optic nerve is similar to wt (Figures 4g–i).
We also show that in primary cultures of wt astrocytes, Bit1
colocalizes with giantin, a Golgi marker (Figures 5a–c). In
Nuc1 astrocytes, however, Bit1 shows minimal colocalization
with giantin (Figures 5d–f), suggesting failure of Bit1
trafﬁcking. It has been reported that Bit1 localizes to the
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Cell Death and Diseaseearly secretory pathway and is enriched in the Golgi, and that
localization in the Golgi is important for anoikis-mediated cell
death.
9 These data further prompted us to use astrocytes to
investigate a possible role for bA3/A1-crystallin in anoikis.
bA3/A1-Crystallin and anoikis-mediated cell death in
astrocytes. Anoikis was induced in astrocytes isolated from
P2 wt and Nuc1 optic nerves by growing the cells in plates
coated with poly-2-hydroxyethyl methacrylate (poly-HEMA)
to prevent adhesion to the substrate. After 5 days in culture,
we observed only small and sparse aggregates of cells in the
wt cultures, whereas Nuc1 cultures showed larger and more
numerous cellular aggregates (Figure 6a). After 3 days of
anoikis induction, cell death was 20% greater in wt cultures
than in Nuc1; by 5 days, cell death in wt cultures was 42-fold
higher than in Nuc1 cultures (Figure 6b). Moreover, MTS
(3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium) assays conducted after 5
Figure 1 Immunoﬂuorescent labeling of Bit1 was performed on frozen sections of wt and Nuc1 homozygous lenses aged E14.5 to P10. At E14.5, Bit1 staining (red) was
visible in the elongating primary ﬁbers and in the lens epithelial cells in both genotypes (a–d). When primary ﬁber cells have ﬁlled the lens vesicle at E17.5 (e–h), both wt and
Nuc1 lens ﬁbers and epithelial cells were positive for Bit1, with similar pattern at E19.5 (i–l). By P3 (m–p), the central ﬁber cells started losing their Bit1 staining. By contrast,
Nuc1mutantsshowedpositivestainingforBit1fromE19.5toP3,withabnormalretentionofnuclei.ByP10(q–t),Bit1stainingintheﬁbersdeclinedfurtherinthewtlensesand
positive staining was seen only in the epithelium and bow region. The Bit1 staining pattern of Nuc1 lenses remained strong both in the ﬁbers and epithelium. Nuclei were
counterstained with DAPI where indicated. Scale bar¼50mm
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Cell Death and Diseasedays of anoikis induction (poly-HEMA) followed by 7 days in
normal culture conditions demonstrated increased
proliferation by Nuc1 cells (Figure 6c). Western blot data
indicated that total PKD protein and phosphorylated PKD are
higher in Nuc1 astrocytes as compared with wt. However, no
difference in the protein levels of Bit1, cleaved caspase-3 or
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Cell Death and Diseaseapoptosis-inducing factor (AIF) was seen between wt and
Nuc1 astrocytes (Figure 6d). To conﬁrm its role in anoikis-
mediated cell death in astrocytes, we knocked down Bit1 in
wt astrocyte using a Bit1-speciﬁc small interfering RNA
(siRNA). Our data show decreased cell death after anoikis
induction in astrocytes where Bit1 is downregulated
(Figure 6e).
Loss of bA3/A1-crystallin inhibits anoikis-mediated cell
death and increases cell survival by modulating the
PI3K/Akt/mTOR and ERK pathways. The PI3K/AKT/
mTOR and p44/42 MAPK (ERK1/2) pathways are known to
promote cell survival. Our data show that in Nuc1 astrocytes,
phosphorylated PI3K, AKT and mTOR are upregulated as
compared with wt after 3 and 5 days of anoikis induction
(Figure 7a). We also found that phosphorylated ERK1/2
protein expression is increased in Nuc1 astrocytes, relative
to wt cells, after anoikis induction (Figure 7a). Whereas
ERK1/2 total protein was equivalent in wt and Nuc1
astrocytes after anoikis induction, total PI3K and AKT
protein were increased in Nuc1 astrocytes as compared
with wt (Figure 7a). Moreover, the phosphorylated form of
integrin-linked kinase (ILK) was also increased in Nuc1
astrocytes as compared with wt after 3 and 5 days of anoikis
induction, whereas total ILK remained unchanged
(Figure 7a).
To determine whether survival of Nuc1 astrocytes is
regulated by the mTOR and ERK1/2 pathways, we treated
wtandNuc1astrocytesfor72hwitheitherrapamycin(10nM),
an inhibitor of mTOR, or the ERK inhibitor FR180204 (10mM).
Results showed a decrease in the proliferation of the Nuc1
astrocytes after treatment with either FR180204 or rapamycin
(Figure7b).Interestingly,thepresenceofbothinhibitorshada
strongereffectthaneitherappliedalone,indicatinganadditive
effect when both pathways were inhibited (Figure 7b). More-
over, when wt and Nuc1 astrocytes were exposed to
FR180204, rapamycin or both under an anoikis condition, a
remarkable increase in cell death was observed in Nuc1
astrocytes but not in wt cells (Figure 7c).
IGF-II expression levels in optic nerve astrocytes. To
identify growth factors that might be responsible for
upregulation of survival pathways in Nuc1 astrocytes, we
evaluated microarray data comparing wt and Nuc1
astrocytes from both the optic nerve and retina (data not
shown). A striking increase in IGF-II was observed in Nuc1
cells. This result was conﬁrmed by quantitative real-time
PCR analysis performed on 2- and 7-day cultures of optic
nerve astrocytes. As shown in Figure 8a, increases of about
27-fold (2 day) and 73-fold (7 day) were observed in the Nuc1
astrocytes as compared with wt when normalized to the
reference gene, Gapdh. Western blot analysis also showed
markedly higher levels of proIGF-II in Nuc1 astrocytes as
compared with wt (Figure 8b).
Discussion
We have hypothesized previously, based onour studies using
the Nuc1 rat model, that bA3/A1-crystallin may have a role in
programmed cell death during ocular development.
21,22,30,31
Nuc1ratshaveacomplexocularphenotype,includingnuclear
cataracts, persistent fetal vasculature disease (PFV) and
abnormalities in retinal vasculature development.
21–23,30,31
bA3/A1-crystallin, a member of the b/g-crystallin superfamily,
is abundantly expressed in differentiating lens ﬁber cells.
Programmed removal ofnuclei and other organelles from lens
ﬁber cells occurs as elongating lens ﬁber cells detach from the
capsule and later inter-digitate with apposing ﬁbers to form
sutures.
32 Anoikis is a form of apoptosis resulting from loss of
cell anchorage.
33 To determine whether anoikis is involved in
denucleation of lens ﬁber cells, we evaluated the expression
patterns of the anoikis regulators, Bit1 and PKD, in the
developing rat lens. Our studies show that expression of both
Bit1 and PKD is modulated during the process of lens
denucleation (Figures 1 and 2). In wt lens, Bit1 and PKD are
highly expressed during embryonic development, when the
organelles are still present in lens ﬁbers, but are down-
regulated as active denucleation is initiated. Interestingly, in
Nuc1 rat, where a mutation in the Cryba1 gene inhibits normal
programmed loss of nuclei, expression of both Bit1 and PKD
remains abnormally high in mature lens ﬁbers. These data
suggest that anoikis may be involved in the lens denucleation
process. To determine whether bA3/A1-crystallin has a role in
anoikis, we induced anoikis in vitro and conducted mechan-
istic studies on astrocytes, cells known to express bA3/A1-
crystallin.
Astrocytes are the only cells in the retina that are
immigrants to the retina, and their numbers appear to be
controlled by a different cell death process than that
functioning in those cell types that are born in the retina.
34,35
Programmed cell death of astrocytes in the rat retina peaks
between P0 and P5, and declines by P15.
36 Interestingly, the
anoikis effectors, Bit1 and PKD, are also expressed in the
developing retina. Our data indicate that in the wt optic nerve
and developing retina, Bit1 is expressed as early as E19
(Figure 3). By P3 Bit1 is expressed by GFAP
þ astrocytes.
Astrocytes ﬁrst appear in the developing rat optic nerve at
E16, but they are immature and do not express GFAP. By P3
they become GFAP
þ (Figure 3). They form a corona of
processes around the optic nerve head by E18, cover
approximately 35% of the retina at birth and reach the
periphery of the retina by P8.
36 Thus, the expression pattern
of Bit1 correlates temporally with the development of
astrocytes, suggesting a role for anoikis-mediated cell death
Figure 2 (A) Photomicrographs of wt and Nuc1 lenses immuno-labeled for PKD (red), an upstream regulator of Bit1. PKD has a staining pattern similar to that of Bit1,
except that lens epithelial cells (arrows) were negative for PKD. Immunostaining showed weak expression of PKD in lens primary ﬁbers at E14.5 both in wt and Nuc1 lenses
(a–d). There was no marked difference in PKD expression between wt and Nuc1 through E19.5 (a–h). At P3 (i–l) PKD staining was diminished in the wt lens, but not in Nuc1,
from the mature ﬁber cells in the core. By P10 (m–p), only ﬁber cells at the equatorial area expressed PKD. In Nuc1, PKD staining was present throughout the disorganized
lens at both P3 and P10. Nuclei were counterstained with DAPI. (B) Western blot analysis showed that PKD protein is expressed at E19.5 in both wt and Nuc1 homozygous
lenses. However, in wt expression decreased markedly by P3 and P10, whereas PKD expression was not downregulated in the Nuc1 homozygous lenses
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Cell Death and Diseasein the regulation of astrocyte cell numbers in the developing
retina. By P10, Bit1 appears to be expressed by Muller cells
(Figures 3 and 4), whereas expression by astrocytes is
downregulated. This raises the interesting possibility that a
population of Muller cells may be controlled by anoikis-
mediated cell death in the developing retina. However, Bit1
may also have other roles in cellular homeostasis that remain
to be determined.
Figure 3 Bit1 (red) and GFAP(green) expressionin opticnerve andretinalastrocytes.In panel (A) (toppanel), immunoﬂuorescent labelingof Bit1 (a) was evident in cells
at the optic nerve head as early as E19. GFAP expression was not seen (b) because only immature astrocytes are present at this age. By P3 (A, middle panel), GFAP
þ
astrocytes (e) express Bit1 (d) in the optic nerve as seen in the merged image (yellow, f). However, at P10 (A, bottom panel), Bit1 (g) co-expression with GFAP was much
reduced (h) in the optic nerve head (i, co-expression mostly in the nerve ﬁber layer of the retina). Panels c, f and i also show DAPI staining of cell nuclei (blue). Fluorescence
microscopy of retinal ﬂat mounts in panel (B), show that at P3 (top panel), Bit1 (a) and GFAP (b) are signiﬁcantly co-expressed (orange, c). The Bit1 expression pattern
changes by P10 (bottom panel) in the retina and GFAP
þ astrocytes (e) no longer express Bit1 (d); expression of Bit1 now appears to be in Muller cells (f)
Figure 4 Bit1 expression in the retina and optic nerve head in normal (a–f) and Nuc1 homozygous rats (g–l) at 2 months of age. Confocal microscopy indicatedthat in wt
optic nerve (panels a–c), Bit1 (red) and GFAP (green) are co-expressed (yellow, c). The expression pattern of Bit1 (red) is different in the wt retina (panels d–f), where Bit1
expression appears to be primarily in Muller cells (d), with little co-expression with GFAP
þ astrocytes. Interestingly, in the Nuc1 homozygous optic nerve (panels g–i) and
especially in the retina (panels j–l) Bit1 (red) and GFAP (green) show greater co-expression than in wt
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Cell Death and DiseaseDisturbances of cell attachment are known to lead to
initiation of anoikis, as demonstrated by our optic nerve
astrocytes cultured on poly-HEMA plates (Figure 6a). Inter-
estingly, anoikis-mediated cell death is reduced in Nuc1 optic
nerve astrocytes cultured on poly-HEMA possibly because
more cells remain attached to each other for survival
(Figure 6a). These data also suggest that loss of bA3/A1-
crystallin impairs anoikis in astrocytes. Cell cytotoxicity
assays clearly show that the level of cell death in wt optic
nerve astrocytes after anoikis induction is much higher than in
Nuc1 astrocytes (Figure 6b).
Our data show increased levels of PKD in Nuc1 astrocytes
after 5 days of anoikis induction, whereas protein levels of
Bit1, cleaved caspase-3 and AIF are similar in wt and mutant
cells under these conditions (Figure 6d). Our studies also
indicate that anoikis-mediated cell death in astrocytes may
occur by modulation of the Bit1–PKD axis (Figure 6e).
Previous studies have indicated that Bit1 induces caspase-
independent apoptosis,
7 that it localizes to the early secretory
pathway and is enriched in the Golgi.
9 In fact, constitutive
expression ofBit1 in the ER canlead toactivation of the ERK–
MAPK pathway and thereby inhibit anoikis.
9 We provide
evidence that, in Nuc1 astrocytes, Bit1 is not co-expressed
normallywiththeGolgimarkergiantin(Figure5)andtherefore
is not enriched in the Golgi. As it has been shown that anoikis
requires Bit1 trafﬁcking to the Golgi,
9 this may explain why
Nuc1astrocytesareabletoevadeanoikiseventhoughPKDis
activated. These data provide novel evidence that bA3/A1-
crystallin is required by astrocytes for trafﬁcking of Bit1 to the
Golgi,whichisessentialforanoikis-mediatedcelldeath.While
we have no direct evidence for a role by bA3/A1-crystallin in
protein trafﬁcking, it is interesting that mutant bA3/A1-
crystallin in Nuc1 fails to properly translocate to lysosomes
in the retinal pigmented epithelium.
37
Our data suggest that loss of functional bA3/A1-crystallin
not only inhibits cell death but also promotes survival of
astrocytes by stimulating proliferation (Figure 6c). In cultured
Nuc1 astrocytes where bA3/A1-crystallin is non-functional,
the phosphorylated forms of PI3K, AKT and mTOR are
signiﬁcantly increased (Figure 7a). The profound inhibition of
anoikis in Nuc1 astrocytes results in the activation of survival
pathways. It has been shown that activation of the PI3K/AKT/
mTOR pathway may also mediate anoikis-suppressing
effects in cells. It has been reported earlier that ILK is capable
of phosphorylating Akt on Ser-473.
38 We show here that
phosphorylated ILK is upregulated in Nuc1 astrocytes after
anoikis induction relative to wt cells (Figure 7a), suggesting a
role for ILK in anoikis-mediated cell death in astrocytes.
Overexpression of ILK in mouse mammary epithelial cells
(SCP2), which are anoikis-sensitive, results in profound
inhibition of anoikis, whereas inhibition of ILK activity induces
anoikis in human breast cancer cell lines that are normally
anoikis-resistant.
38 ILK activity can also be triggered by
growth factor stimulation in a PI3K-dependent manner.
12
It has generally been accepted that the PI3K/AKT pathway
is involved in regulation of cell survival induced by growth
factors. In a recent study, it has been shown that IGF-II can
activate both the PI3K/AKT and ERK pathways in ovine
trophectoderm cells.
15 Our results raise the distinct possibility
that loss of bA3/A1-crystallin can stimulate expression of
IGF-II, which could regulate cell survival through the PI3K/
AKT/mTOR and ERK signaling cascades. IGF-II has been
shown to promote the survival of glial cells in the developing
optic nerve.
27
To further investigate whether loss of bA3/A1-crystallin can
drivecellstoasurvivalpathwaythroughPI3K/AKT/mTOR,we
treated wt and Nuc1 astrocytes with rapamycin. Interestingly,
exposing wt cells to rapamycin, an inhibitor of mTOR, did not
alter cell death. However, in Nuc1 astrocyte cultures,
rapamycin treatment reverses the suppressive effect of
mutant bA3/A1-crystallin on anoikis (Figure 7b). Although
Nuc1 astrocytes, when treated with rapamycin, underwent
increased cell death, cell proliferation was still higher than that
inwt astrocytes. These data suggestthat a secondpathway is
involved in the increased survival of Nuc1 astrocytes. We
therefore investigated the ERK pathway because PKD has
been shown to negatively regulate ERK. In Nuc1 astrocytes,
PKD is activated, however Bit1 is not trafﬁcked to the Golgi
Figure 5 Fluorescenceimmunohistochemistryonculturedastrocytesfromtheopticnerveofwt(a–c)andNuc1homozygousrats(d–f),usingantibodyto Bit1(green)and
giantin (Golgi marker, red). Strong colocalization of Bit1 and giantin staining (c, arrows) is shown in the wt astrocytes. In Nuc1 astrocytes, however, Bit1 shows minimal
colocalization with giantin (f). The bar represents 50mm
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Cell Death and Diseaseand therefore anoikis is suppressed. We therefore envisioned
that in Nuc1 astrocytes, PKD may activate ERK as Bit1 fails to
accumulate in the Golgi and the anoikis pathway is not
activated. Our data do show that phosphorylated ERK1 and
ERK2 are signiﬁcantly increased in Nuc1 astrocytes as
compared with wt after 3 and 7 days of anoikis induction,
whereastotalERKproteinlevelsremainunchangedinbothwt
and mutant astrocytes (Figure 7a). Moreover, treatment of
Nuc1 astrocytes with the ERK inhibitor, FR180204, induced
increased cell death relative to wt astrocytes. This effect was
not as great as that seen with the mTOR inhibitor rapamycin.
There appeared to be an additive effect on increased
cell death when both inhibitors were used concomitantly,
suggestingthatboththePI3K/AKT/mTORandERKpathways
areinvolved.Furthermore, wealsoshow thatNuc1astrocytes
treated with the above inhibitors under an anoikis condition
undergo increased cell death as compared with wt cells.
We therefore provide evidence that bA3/A1-crystallin
participates in cell death mechanisms essential for tissue
remodeling during ocular development by suppressing
survival pathways.
In conclusion, our data provide evidence that bA3/A1-
crystallin has a pivotal role in anoikis, a process necessary for
tissue remodeling during eye development. Loss of this
protein not only inhibits anoikis by affecting trafﬁcking of Bit1
to the Golgi, but also activates PI3K/ERK-related survival
signaling pathways, possibly through regulation of IGF-II,
PKD and ILK expression (Figure 8c). Cell death during
development is essential for organogenesis and crafting of
complex multicellular tissues.
39,40 In the eye, various forms of
cell death occurring during development are essential for
maturation of the tissue, and a defect in the process can lead
to ocular diseases.
Materials and Methods
Animals. ExperimentswereperformedusingembryonicandpostnatalNuc1and
wt Sprague–Dawley rats, in accordance with the Guide for the Care and Use of
Laboratory Animals (National Academy Press).
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Figure 6 (a) Astrocytes were isolated from the optic nerve of wt and Nuc1 rats and cultured on poly-HEMA plates to induce anoikis. After 5 days on poly-HEMA, Nuc1
astrocytes show signiﬁcantly higher survival than wt. The upper panels show representative images of wt astrocytes and the lower panels show Nuc1 cultures with larger and
morenumerouscellularaggregates.(b)CelldeathassayperformedbyusingtheCellDeathDetectionELISA
Pluskitafter3and5daysofanoikisinductionshows,respectively,
approximately 20% and 50% less cell death in Nuc1 cultures as compared with wt. Results were plotted as absorbance at 405nm, with a reference wavelength of 490nm.
Experimentswereperformedintriplicate.P-valueswerecalculatedbyStudent’st-test(*P¼0.001).(c)Tomeasureproliferation,MTSassaywasperformedwithNuc1andwt
astrocytes after 5 days of anoikis induction, followed by culture under normal conditions for 0, 4 and 7 days. Signiﬁcant increase in cell proliferation was observed in Nuc1
culturesascomparedwithwt.Thedatarepresentthemeanvaluesofabsorbanceatwavelength490nm,whichisproportionaltothenumberofviablecells.Experimentswere
performed in triplicate. P-values were calculated by Student’s t-test (*P¼0.05). (d) Immunoblot analyses were performed using antibodies against Bit1, PKD, phospho-PKD
(Ser916 and Ser744/748), caspase-3, AIF and b-actin on lysates of wt and Nuc1 astrocytes after 3 days of anoikis induction as described under Materials and Methods. The
data indicate an increase in phospho-PKD and total PKD in Nuc1 astrocytes as compared with wt. No difference in the expression patterns of Bit1, cleaved caspase-3 or AIF
was seen between wt and Nuc1 astrocytes. (e) Bit1 was knocked down in wt astrocytes (western blot in inset) using a Bit1-speciﬁc siRNA as described under Materials and
Methods. The data indicate that cell death was decreased in Bit1-knocked-down astrocytes after anoikis induction as described under panel a. The data represent the mean
values of absorbance at wavelength 490nm, which is proportional to the number of viable cells. Experiments were performed in triplicate. P-values were calculated by
Student’s t-test (*P¼0.05)
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induction. Optic nerve astrocytes from P2 wt and Nuc1 homozygous rats
were cultured as described recently.
23 Cells were maintained in DMEM-F12
medium containing 10% FBS. To induce anoikis, 2.5 10
5 cells per well were
seeded in six-well plates coated with poly-HEMA (Corning Inc., Corning, NY, USA).
After 3 or 5 days of culture under low-attachment conditions, cells were analyzed or
transferred to normal medium for later use. Photomicrographs were taken with an
inverted microscope (Motic, Richmond, BC, Canada) at  4 magniﬁcation.
siRNA knockdown. SiRNA duplex oligoribonucleotides for siRNA-targeted
disruption of rat Bit1 (GenBank no. NM_001013860) were purchased from
Dharmacon(Lafayette,CO,USA).AscrambledsiRNAwasalsopurchasedfromthe
same company and did not target any genes. Cultured astrocytes were transfected
with 20nM Bit1 or scrambled siRNA by using the Lipofectamine RNAiMAX reagent
(Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instruction.
Knockdown of expression of Bit1 was veriﬁed by western blot analysis. Forty-eight
hoursaftertransfection,cells wereseededinsix-well platescoated with poly-HEMA
for further experiments.
Cell proliferation assay. Cell proliferation was determined by MTS
colorimetric assay performed using 96-well plates (Promega, Madison, WI, USA)
following the manufacturer’s protocol. Astrocytes were cultured under low-
attachment conditions to induce anoikis for 5 days and were later seeded in
CellTiter 96 cytotoxicity assay plates at 4 10
3 cells per well in 10% FBS medium.
Cellnumbersweredeterminedat0and7daysofincubationbyadding20mlofMTS
solution to each well. After 1h of incubation at 371C, absorbance, which is
proportionaltothenumberofviablecells,wasmeasuredatawavelengthof490nm.
Experiments were performed in triplicate.
Cell death assay. Cell death evaluation by ELISA using the colorimetric Cell
Death Detection ELISA
Plus kit (Roche Applied Science, Indianapolis, IN, USA) was
performedusing96-wellstripsaccordingtothemanufacturer’sprotocol.Therelative
amounts of mono- and oligonucleosomes generated from the apoptotic cells were
quantiﬁed by using monoclonal antibodies directed against DNA and histones
by ELISA. Brieﬂy, wt and Nuc1 astrocytes were cultured under low-attachment
conditions to induce anoikis for 3 and 5 days. The cytoplasmic fractions of wt
and Nuc1 astrocytes were transferred onto a streptavidin-coated 96-well plate
and incubated for 2h at room temperature with a mixture of a peroxidase-
conjugated anti-DNA and biotin-labeled anti-histone antibody. The plate was
washed thoroughly, incubated with 2,20-azino-di-(3-ethylbenzthiazoline sulfonate)
diammonium salt and absorbance was measured at 405nm, using a reference
wavelength of 490nm (DTX 880 Multimode Reader, Beckman Coulter Inc., Brea,
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Figure 7 (a) To identify pathways activated in wt and the Nuc1 astrocytes after anoikis induction, western blot analyses were performed for total and phospho-PI3K, total
andphospho-ILK, totalandphospho-AKT, totalandphospho-mTOR, totalandphospho-ERK1/2,and b-actin.After3 and5 daysofanoikisinduction,Nuc1astrocytes showa
robustincreaseofphosphorylatedPI3K,AKT,mTOR,ILKandERK1/2comparedwithwt.(b)MTSassayswereperformedaftertreatmentofwtandNuc1astrocytesfor3days
with either the mTORinhibitor, rapamycin(10nM), or the ERK inhibitorFR180204(10mM), as well as combinedtreatment with rapamycin(10nM) and FR180204(10mM) as
described under Materials and Methods. The results show a decrease in proliferation of Nuc1 astrocytes after treatment with either rapamycin or FR180204. When both
inhibitors were used together, an additive effect was observed. , wt astrocyte with FR180204treatment; , Wt astrocyte with rapamycin treatment; ,w t
astrocyte with rapamycin and FR180204 treatment; , Nuc1 astrocyte with FR180204 treatment; , Nuc1 astrocyte with rapamycin treatment; , Nuc1
astrocyte with rapamycin and FR180204 treatment. (c) Cell death assays were performed on wt and Nuc1 astrocytes after culture on poly-HEMA plates for 3 days to induce
anoikis and an additional 3 days (still on poly-HEMA) with either the mTOR inhibitor, rapamycin (10nM), or the ERK inhibitor FR180204 (10mM), as well as combined
treatmentwith rapamycin(10nM) andFR180204(10mM). Theresultsindicate an increasedcelldeath of Nuc1astrocytesafter treatmentwith eitherrapamycinorFR180204.
An additive effect was observed when both inhibitors were combined. , wt astrocyte with FR180204 treatment; , wt astrocyte with rapamycin treatment;
, wt astrocyte with rapamycin and FR180204 treatment; , Nuc1 astrocyte with FR180204 treatment; , Nuc1 astrocyte with rapamycin treatment;
,Nuc1astrocytewithrapamycinandFR180204treatment.ForMTS(cellproliferationassay),thedatarepresentthemeanvaluesofabsorbanceatwavelength490nm,
which is proportional to the number of viable cells. For cell death assay, results were plotted as absorbance at 405nm, with a reference wavelength of 490nm. Experiments
were performed in triplicate. P-values were calculated between Nuc1 and wt astrocytes by Student’s t-test (*P¼0.001)
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Cell Death and DiseaseCA, USA). All conditions were repeated in triplicate in at least two independent
experiments and results were evaluated by Student’s t-test.
Immunoﬂuorescence studies. Immunoﬂuorescence was performed on
frozen sections and retinal ﬂat mounts or cultured astrocytes as described
earlier.
22,23 Brieﬂy, samples were incubated in phosphate-buffered saline (PBS),
containing 5% normal goatserum,for 30min prior to beingincubatedovernightwith
primary antibodies at 41C; washed in PBS; incubated for 1h at room temperature
with secondary antibodies; and washed again with PBS. Sections were mounted
with the DAKO ﬂuorescent mounting medium (DAKO Corporation, Carpentaria,
CA, USA). The primary polyclonal rabbit antibodies used were PKD (1:500;
Abcam, Cambridge, MA, USA), Bit1 (1:500; Abcam), giantin (1:50; Abcam). The
secondary antibodies used were goat anti-rabbit IgG conjugated with Cy3 (1:200;
Jackson Immunoresearch, West Grove, PA, USA) for both PKD and Bit1, and
Alexa-Fluor-568 donkey anti-mouse IgG (Invitrogen) for giantin. Fluorescent
digital images were acquired with a Leica 6000 ﬂuorescent microscope (Leica
Microsystems,Wetzlar, Germany).Retinal ﬂat mountswere analyzedby Zeiss LSM
510 confocal microscope (Carl Zeiss Microimaging, LLC, Thornwood, NY, USA).
SDS-PAGE and western blot analysis. Lenses were dissected from wt
and Nuc1 eyes by the posterior approach. Lens tissue was rinsed in PBS and
homogenized in the Mammalian Protein Extraction Reagent (M-PER) (Thermo
Fisher Scientiﬁc, Rockford, IL, USA) with 1% 0.5M EDTA and 1% protease inhibitor
cocktail (Sigma-Aldrich, St. Louis, MO, USA), and 1mM EDTA. Samples were
incubatedat41Cfor30minonanend-over-endshaker,followedbycentrifugationat
13000 g for 15min. Wt and Nuc1 astrocytes, after 3 and 7 days of anoikis
induction, were lysed on ice for 30min in RIPA buffer (50mM NaCl, 100mM Tris
(pH 8.0), 1% Triton X-100, 1% deoxycholic acid, 0.1% SDS, 5mM EDTA and
10mM NaF, supplemented with 1mM phenylmethylsulfonyl ﬂuoride) and protease
inhibitor mixture (Sigma-Aldrich). After centrifugation at 13000 g for 15min, the
supernatant was harvested as the total cellular protein extract. Protein quantiﬁcation
was performed by using the Quick Start Bradford Protein Assay (Bio-Rad
Laboratories, Hercules, CA, USA). Approximately 25mg of protein from the
supernatant was mixed with 2  LDS sample buffer (Invitrogen) and then heated in
a boiling water bath for 3min. Each sample was loaded onto a 4–12%
Bis-Tris Nu-PAGE gel and run with MES buffer (Invitrogen). For western blotting,
proteinsweretransferredtonitrocellulosemembrane(Invitrogen)for90minandthen
blocked with 3% bovine serum albumin (BSA) in Tris-buffered saline (TTBS, 0.1%
Tween-20)overnightat41C.BlotswereincubatedwithantibodiestoeitherBit1,PKD
(Abcam; at 1:1000 dilution); AIF (Santa Cruz Biotechnology, Santa Cruz, CA, USA;
at 1:1000 dilution); caspase-3, total PI3K, AKT, p44/42 MAPK (Erk1/2), mTOR,
phospho-PI3K (p85 (Tyr458)/p55 (Tyr199)), phospho-AKT (Ser473), phospho-p44/
42 MAPK (Erk1/2) (Thr202/Tyr204), phospho-PKD (Ser916 and Ser744/748) and
mTOR (Ser2448) (all from Cell Signaling Technology Inc., Danvers, MA, USA; all at
1:1000 dilution); or an anti-IGF-II antibody (clone S1F2, Millipore, Billerica, MA,
USA; at 1:500 dilution). Blots were incubated with HRP-conjugated secondary
antibodies (Kirkegaard and Perry Laboratories, Gaithersburg, MD, USA) for 1h at
room temperature at a dilution of 1:5000, followed by four washes of 10min each.
ECL western blotting detection reagents (GE Healthcare, Piscataway, NJ, USA)
were used for detection with varying exposure times.
Real-timeRT-PCR. TotalRNAwasextractedfromwtandNuc1cellsusingthe
RNeasy Plus Mini Kit (Qiagen, Valencia, CA, USA) following the manufacturer’s
instructions and was quantiﬁed with a Nanodrop ND-1000 spectrophotometer
(Thermo Scientiﬁc, Wilmington, DE, USA). A 2-mg weight of total RNA was reverse-
transcribed to cDNA in a 20-ml reaction volume using the SuperScript reverse
transcription kit (Invitrogen). Reverse transcription reaction was performed
according to the manufacturer’s instructions. PCR ampliﬁcation was performed by
using the 7500 PCR Fast Real-Time System (Applied Biosystems, Foster City, CA,
USA)andcustom-madeTaqManprobesforIGF-II(Rn01454518_m1*)andGAPDH
(Rn01775763_g1*). The reaction consisted of the following steps: enzyme
activation at 951C for 20s, 40 cycles of denaturation at 951C for 3s, combined
with annealing/extension at 601C for 30s. All data were analyzed by using the ABI
7500 Real-Time PCR System, using the DataAssist software (Applied Biosystems),
and graphs were plotted by using Microsoft Excel. All data are representative of
experimentsperformedatleastthreetimesintriplicate.Thedataarerepresentedas
mean±S.D. For statistical analysis, Student’s t-test was performed and a P-value
of o0.05 was considered statistically signiﬁcant.
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Figure 8 (a) Total RNA from 2- and 7-day cultures of wt and Nuc1 optic nerve
astrocytes was assessed for reference (GAPDH) and target gene (IGF-II) by qRT-
PCR. Fold change was calculated by the DDCT method after normalizing to
GAPDH. Because of the small number of IGF transcripts in the wt sample, an
arbitrary CT value of 40 was assigned to the wt sample to measure fold change.
(b) Western blot analysis for proIGF-II expression in a 7-day culture of wt and Nuc1
optic nerve astrocytes. The immunoreactive bands at B20–21kDa corresponding
to the molecular weight of proIGF-II were upregulated in the Nuc1 astrocytes as
compared with the wt astrocytes. b-Actin was used as a loading control.
(c) A hypothetical model showing possible actions of bA3/A1-crystallin in the
regulation of anoikis. For induction of anoikis, trafﬁcking of Bit1 to the Golgi is
essential, and our data suggest that bA3/A1-crystallin is required in this process.
bA3/A1-crystallin may also regulate the balance between cell death and survival of
astrocytes by inhibiting growth factors, such as IGF-II, which are upstream from the
survival pathways PI3K/ILK/AKT/mTOR and ERK. Loss of this protein may inhibit
anoikis not only by affecting trafﬁcking of Bit1 to the Golgi, but also by activating
PI3K/ERK-relatedsurvivalsignalingpathwaysthroughregulationofIGF-II,PKDand
ILK expression
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